Evidence map›Paper›PMID 29268096›Full record

ArticleNeuron2017

Activation of the STING-Dependent Type I Interferon Response Reduces Microglial Reactivity and Neuroinflammation.

Vidhu Mathur, Ritwik Burai, Ryan T Vest, Liana N Bonanno, Benoit Lehallier, Macy E Zardeneta, Karishma N Mistry, Danny Do, Samuel E Marsh, Edsel M Abud and 4 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Neuron, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06436534 (A Randomized, Double-blind, Placebo-controlled, Single-center Clinical Trial of Ganciclovir Capsules in the Treatment of Refractory Moderate-to-severe Allergic Rhinitis), which is not on this map. Cited by 105 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06436534 narecruitingnot on this mapstarted 2024, after this paper: background citation

A Randomized, Double-blind, Placebo-controlled, Single-center Clinical Trial of Ganciclovir Capsules in the Treatment of Refractory Moderate-to-severe Allergic Rhinitis

TypeinterventionalSponsorUnion Hospital, Tongji Medical College, Huazhong University of Science and TechnologyRan2024 to 2026Enrolled50ConditionsRhinitis, AllergicArmsGanciclovir Oral Capsule, Ganciclovir Simulant Oral Capsule, Mometasone Nasal
3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 1 synthesis or guideline pooled it, 164 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Targeting the cGAS-STING pathway mitigates Huntington disease pathogenesis in a knock-in mouse model.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Review
  9. Expanding roles of cGAS-STING signaling in neuroinflammation.The Journal of clinical investigation · 2026
    Review
  10. Article
  11. Article
  12. cGAS inhibition delays TDP-43-driven ALS Pathogenesis.bioRxiv : the preprint server for biology · 2026
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Vidhu MathurDepartment of Neurology and Neurological Sciences, School of Medicine, Stanford University, Stanford, CA 94305, USA; Center for Tissue Regeneration, Repair and Rehabilitation, VA Palo Alto Health Care System, Palo Alto, CA 94304, USA.
Ritwik BuraiLaboratory of Molecular and Chemical Biology of Neurodegeneration, Brain Mind Institute, Station 19, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland.
Ryan T VestChemical Engineering Graduate Program, School of Engineering, Stanford University, Stanford, CA 94305, USA.
Liana N BonannoDepartment of Neurology and Neurological Sciences, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Benoit LehallierDepartment of Neurology and Neurological Sciences, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Macy E ZardenetaCenter for Tissue Regeneration, Repair and Rehabilitation, VA Palo Alto Health Care System, Palo Alto, CA 94304, USA.
Karishma N MistryCenter for Tissue Regeneration, Repair and Rehabilitation, VA Palo Alto Health Care System, Palo Alto, CA 94304, USA.
Danny DoDepartment of Neurology and Neurological Sciences, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Samuel E MarshInstitute for Memory Impairments and Neurological Disorders, University of California, Irvine, Irvine, CA 92697, USA.
Edsel M AbudInstitute for Memory Impairments and Neurological Disorders, University of California, Irvine, Irvine, CA 92697, USA.
Mathew Blurton-JonesInstitute for Memory Impairments and Neurological Disorders, University of California, Irvine, Irvine, CA 92697, USA.
Lingyin LiBiochemistry Department, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Hilal A LashuelLaboratory of Molecular and Chemical Biology of Neurodegeneration, Brain Mind Institute, Station 19, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland.
Tony Wyss-CorayDepartment of Neurology and Neurological Sciences, School of Medicine, Stanford University, Stanford, CA 94305, USA; Center for Tissue Regeneration, Repair and Rehabilitation, VA Palo Alto Health Care System, Palo Alto, CA 94304, USA. Electronic address: twc@stanford.edu.
Stanford University · USUniversity of California, Irvine · USÉcole Polytechnique Fédérale de Lausanne · CHVA Palo Alto Health Care System · US

Funding

Working Memory in Parkinson Disease: A Cognitive & Systems Neuroscience ApproachP50AG047366 · NIA · STANFORD UNIVERSITY · PI TIAN, LU · 2015 to 2019
$7.9M
Circulatory Rejuvenating Factors for the BrainR01AG045034 · NIA · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI WYSS-CORAY, TONY · 2013 to 2017
$1.4M
Aging and Inflammation in Mild Traumatic Brain InjuryI01RX001218 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI WYSS-CORAY, TONY · 2014 to 2018
–
NIA NIH HHS P50 AG047366NIA NIH HHS R01 AG045034RRD VA I01 RX001218
6 · The paper itself

Abstract

Brain aging and neurodegeneration are associated with prominent microglial reactivity and activation of innate immune response pathways, commonly referred to as neuroinflammation. One such pathway, the type I interferon response, recognizes viral or mitochondrial DNA in the cytoplasm via activation of the recently discovered cyclic dinucleotide synthetase cGAS and the cyclic dinucleotide receptor STING. Here we show that the FDA-approved antiviral drug ganciclovir (GCV) induces a type I interferon response independent of its canonical thymidine kinase target. Inhibition of components of the STING pathway, including STING, IRF3, Tbk1, extracellular IFNβ, and the Jak-Stat pathway resulted in reduced activity of GCV and its derivatives. Importantly, functional STING was necessary for GCV to inhibit inflammation in cultured myeloid cells and in a mouse model of multiple sclerosis. Collectively, our findings uncover an unexpected new activity of GCV and identify the STING pathway as a regulator of microglial reactivity and neuroinflammation.

Indexed as

AnimalsAnimals, NewbornAntiviral AgentsCells, CulturedDisease Models, AnimalEncephalomyelitis, Autoimmune, ExperimentalFemaleFreund's AdjuvantGanciclovirGene Expression RegulationHumansInterferon Type IMaleMembrane ProteinsMiceMice, Inbred C57BLAntiviral AgentsFreund's AdjuvantGanciclovirInterferon Type IMembrane ProteinsMyelin-Oligodendrocyte Glycoproteinmyelin oligodendrocyte glycoprotein (35-55)Peptide FragmentsPertussis ToxinSting1 protein, mouseSTING Proteinexperimental autoimmune encephalomyelitisganciclovirmicroglianeuroinflammationSTINGtype I interferon response

Identifiers

PMID29268096
PMCPMC5806703
OpenAlexW2770682151

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.